Thursday, April 26, 2012

Astra CEO Quits; Generics Giant Created as Watson Nabs Actavis - Apr. 26, 2012

Having trouble viewing this email? View in Browser.
BioSpace GenePool
   Thursday, April 26, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide cost effective coverage for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. The majority of our clinical staff are MDs or PhDs, including oncologists in strategic areas for clinical trials. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
Top Stories 
•  AstraZeneca PLC (AZN) CEO Quits More...
•  Generics Giant Created as Watson Pharmaceuticals, Inc. (WPI) Nabs Actavis More...
•  Epizyme Gets $90 Million in Epigenetics Partnership With Celgene Corporation (CELG) More...
•  Amgen (AMGN) to Create 100 Jobs in US $200 Million Expansion More...
•  Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Successor Drug to Actos Fails to Win FDA Approval More...
•  Pfizer Inc. (PFE) Drug Reduced Autism Signs in Mice More...
•  Onyx Pharmaceuticals, Inc. (ONXX) Shares Rally Late Afternoon Amid Rumor of Bayer AG (BAY.F) Acquisition More...
•  Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. (AMLN) CEO More...
More Top News
Don't Miss This

Please Join Aptuit at their Medicines Research Centre in Verona Italy

Drug Discovery and Development is an expensive and high-risk business that can take 10 years from inception to the commercialization of a new drug. Often associated with high attrition rates, it is driven by medical need, disease prevalence and likelihood of success. Drug Development has traditionally been a long and extensive process designed for a staged assessment of the safety, efficacy and manufacture of a drug candidate. On May 16, 2012, Aptuit will welcome nine distinguished representatives from academia and industry to speak at this FREE symposium where they will cover and discuss aspects and strategies to reduce risk, costs and timelines from Candidate Selection to Phase II Clinical Trials.

For a full description of this event, and to register, please go to: www.aptuit.com/verona/paradigms/introduction.aspx.
Featured Stories
•  How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are Incurred in Phase III More...
•  Do Pharma Boards Meet Their Responsibilities? More...
•  Eating More Berries May Delay Memory Decline, Harvard Medical School Study More...
•  Poor Sleep Heightens "Ringing Ear" Disease Symptoms, Henry Ford Health System Study More...
•  A New "Achilles' Heel" in Fungus That Causes Dandruff, Journal of Medicinal Chemistry Reveals More...
•  A Striking Link is Found Between the Fragile-X Gene and Mutations That Cause Autism, Cold Spring Harbor Laboratory Study More...
•  Leafy Greens Help Prevent Damage Caused by a Workout, Edinburgh Napier University Study More...
•  Top 10 Toxic Chemicals Suspected to Cause Autism and Learning Disabilities, Mount Sinai School of Medicine Study More...
Tower: Facebook
  More Featured News
Event of the day

SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively)

The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication.

The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization.

COURSE SEATING IS LIMITED AND USUALLY SELLS OUT!

San Diego, CA
Boot Camp I May 15-16, 2012
Boot Camp II May 17, 2012

Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com.
Latest Market Insight

Vaccines Market Access in India - New Vaccine Uptake Drives Growth

• Review the current regulatory processes, pricing mechanisms, and vaccination schedule in India.
• Identify major multinational and domestic players, view their product portfolios and pipelines, and understand their expansion strategies..
• Examine the major drivers and resistors of the current Indian vaccine market and understand the key opportunities and threats facing developers.

Click Here for More Information.
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
Top Jobs
Pharm Country (Somerville, New Jersey)

Heron Health
Director - Evidence, Pricing & Access
Ensuring that all projects are being conducted in an efficient manner and that quality and client satisfaction is maximized at all times, and that the direction of the project and quality of the deliverables meet both the project objectives and the client needs.

Biotech Beach (Santa Monica, California)

Astellas Pharma US
Environmental Health and Safety Officer
Will facilitate compliance with all applicable environmental, health, and safety principles, guidelines, and legal requirements; deliver, coordinate, and track lab safety training activities; create and maintain company safety practices and manuals; coordinate safety inspections and direct the EH&S program.

Rocky Bio (Salt Lake City, Utah)

Watson Pharmaceuticals, Inc.
Manager, Regulatory Affairs Proprietary
Under general direction, functions as primary regulatory contact with regulatory authorities for assigned products and projects. Manages preparation of regulatory submissions, briefing packages and presentations for regulatory agency meetings. Determines nature, scope and format of information to be generated in order to successfully: file and maintain INDs/CTAs; file regulatory dossiers; respond to health authority inquiries; maintain product registrations and obtain international market access.

BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Medical Director, Pharmacovigilance
Serves as the Global Safety Lead physician for complex, strategically important developmental programs especially those that are Phase III and IV programs. Responsible for the oversight of signal detection and risk management activities for designated global products. Ensures patient safety is adequately addressed in TGRD sponsored studies.

Genetown (Cambridge, Massachusetts)

AVEO Pharmaceuticals, Inc.
Scientist, Pharmacology
Will lead and participate in the evaluation of antibody drug candidates in relevant in vivo models of cancer including proof of concept, target validation, PK/PD relationships as well as efficacy.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

Pharm Country

Pharm Country Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Gilead Sciences, Inc. (Seattle, WA)
199 East Blaine Street
Seattle, Washington 98102 U.S.A.
Phone: 206-728-5090 Fax: 206-728-5095

Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

More Company Profiles
Free Resources
FREE Subscription to Lab Manager Magazine

Lab Manager Magazine helps provide a forum and a framework to help lab professionals hire and supervise staff, establish a laboratory, and plan a coherent research program, while keeping the goals of good science and scientific discovery at the forefront.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: